Most sporadic CRCs lose APC function during adenoma development; then, mutations in other tumor suppressor genes or oncogenes, including TP53, KRAS, and SMAD4, lead to CRC initiation, promotion, and progression [141,142]. This evidence concerns the gene APC and colorectal carcinoma.